Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome
Viviana Versace, Paola Ortelli, Sabrina Dezi, Davide Ferrazzoli, Alessia Alibardi, Ilenia Bonini, Michael Engl, Roberto Maestri, Martina Assogna, Valentina Ajello, Elke Pucks‐Faes, Leopold Saltuari, Luca Sebastianelli, Markus Köfler, Giacomo Koch
Topics & Concepts
PalmitoylethanolamideCoronavirus disease 2019 (COVID-19)NeuroscienceMedicineInternal medicineBiologyReceptorAntagonistInfectious disease (medical specialty)Cannabinoid receptorDiseaseCannabis and Cannabinoid ResearchLong-Term Effects of COVID-19Vagus Nerve Stimulation Research